FDMT vs FTNT · rev $37.0K vs P/E 56, rev $6.80B
4D Molecular Therapeutics Inc (FDMT) versus Fortinet Inc (FTNT) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
FDMT currently screens at market cap $518.1M. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Not investment advice. Open the FDMT and FTNT stock pages for the full models.
Not investment advice.